Open AccessCan spironolactone be used to prevent COVID-19-induced acute respiratory distress syndrome in patients with hypertension?
Author(s) -
Flavio Cadegiani
Publication year - 2020
Publication title -
ajp endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.507
H-Index - 201
eISSN - 1522-1555
pISSN - 0193-1849
DOI - 10.1152/ajpendo.00136.2020
Subject(s) - spironolactone , covid-19 , medicine , respiratory distress , acute respiratory distress , respiratory system , intensive care medicine , cardiology , anesthesia , virology , aldosterone , lung , disease , infectious disease (medical specialty) , outbreak
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom